אוגמנטין תרחיף 125 מ"ג/5 מ"ל

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

AMOXICILLIN AS TRIHYDRATE 125 MG / 5 ML; CLAVULANIC ACID AS POTASSIUM 31.25 MG / 5 ML

Commercializzato da:

GLAXO SMITH KLINE (ISRAEL) LTD

Codice ATC:

J01CR01

Forma farmaceutica:

SUSPENSION

Via di somministrazione:

PER OS

Prodotto da:

SMITHKLINE BEECHAM PLC, UK

Gruppo terapeutico:

AMPICILLIN AND ENZYME INHIBITOR

Indicazioni terapeutiche:

Fot the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused also by beta-lactamase producing organisms which are susceptible to Augmentin and are resistant to other beta-lactam antibiotics.

Data dell'autorizzazione:

2012-09-01